MAPT and Alzheimer disease: 1995). Interestingly, many molecules implicated in AD are associated with or sensitive to binding AGE products (reviewed in Li et al. 2012a) and these products were shown to induce tau hyperphosphorylation, resulting in impairments in synapse function and memory in rats (Li et al. 2012b).